International study for people with CDKL5 disorder
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study is for anyone diagnosed with CDKL5 disorder who can be seen at participating clinics or is already listed in an international CDKL5 registry. The goal is to help researchers better understand the condition and support future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a confirmed diagnosis of CDKL5 disorder (CDD/CDKL5-related disorder)
- Be within the age range of 1 month to 100 years
- Be able to receive care at a participating study center, or be registered in the International CDKL5 Disorder Database
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking daily warm baths at home can safely reduce seizures in children with CDKL5 deficiency disorder. It may help families looking for a non-medication way to manage seizures.
This trial tests a new medicine, ganaxolone, to see if it can reduce seizures in babies and toddlers with CDKL5 deficiency disorder. It aims to help children whose seizures are not controlled by current medications.
This research study aims to better understand Down syndrome by collecting health information, family history, and sometimes brain imaging or sleep data from children and adults with Down syndrome and their families. The goal is to advance knowledge that could improve health and development for people with Down syndrome.
This study follows people with cerebral adrenoleukodystrophy (CALD) who have been treated with eli-cel, a gene therapy. It tracks their long-term health to see how well the treatment works in everyday care.
This study looks at cleidocranial dysplasia (CCD) using a person’s symptoms and/or genetic findings to better understand what needs care and support. It may help teams improve how CCD is recognized and managed over time.
This study follows people with SLC13A5 deficiency (a rare genetic condition that affects brain development) to learn more about the disease over time. It collects health information, assessments, and samples to help understand the condition and plan future treatments.
Hear when a new CDKL5 Deficiency Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.